E2 ModerateModerate confidencePEM unclearCross-SectionalPeer-reviewedMachine draft
Failure to Detect XMRV-Specific Antibodies in the Plasma of CFS Patients Using Highly Sensitive Chemiluminescence Immunoassays.
Oakes, Brendan, Qiu, Xiaoxing, Levine, Susan et al. · Advances in virology · 2011 · DOI
Quick Summary
In 2009, researchers claimed they found a virus called XMRV in most ME/CFS patients' blood. This study tested whether that finding was real by looking for antibodies (immune system markers) to XMRV in blood samples from ME/CFS patients and healthy people. The researchers found no evidence of XMRV antibodies in any of the samples, suggesting the original finding may not have been accurate.
Why It Matters
This study addresses a major controversy in ME/CFS research that created hope and confusion among patients. Definitively ruling out XMRV redirects research toward other potential causes and prevents further investment in a dead-end investigative pathway, allowing resources to focus on more promising hypotheses.
Observed Findings
- No XMRV-specific antibodies were detected in any plasma samples from CFS patients using chemiluminescence immunoassays
- No XMRV-specific antibodies were detected in healthy control samples
- This finding is consistent with the authors' previous negative PCR results for XMRV
- The highly sensitive CMIA methodology did not confirm the 67% seropositivity rate from the Lombardi 2009 study
Inferred Conclusions
- XMRV is not present in the studied human populations, whether CFS patients or healthy individuals
- The original Lombardi findings reporting high XMRV prevalence in CFS patients cannot be confirmed using independent serological methods
- XMRV is unlikely to be a significant pathogenic agent in ME/CFS
Remaining Questions
- Why did the original Lombardi study report 67% XMRV seropositivity while independent laboratories consistently found no evidence of XMRV?
- Could XMRV be present in specific ME/CFS subpopulations not adequately represented in this cohort?
- What is the actual infectious or immune trigger in ME/CFS patients if XMRV has been excluded?
What This Study Does Not Prove
This study does not prove that no infectious agent plays a role in ME/CFS—only that XMRV specifically is not detectable in the tested populations. It also does not explain why the original Lombardi study reported different results, which could reflect differences in laboratory techniques, sample handling, or study populations rather than absence of XMRV.
Tags
Biomarker:AutoantibodiesBlood Biomarker
Method Flag:No ControlsExploratory Only
Metadata
- DOI
- 10.1155/2011/854540
- PMID
- 22312356
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →